Compare CRDO & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDO | MDLN |
|---|---|---|
| Founded | 2008 | 1966 |
| Country | Cayman Islands | United States |
| Employees | N/A | 45000 |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8B | 37.4B |
| IPO Year | 2022 | N/A |
| Metric | CRDO | MDLN |
|---|---|---|
| Price | $300.04 | $35.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 23 |
| Target Price | ★ $179.62 | $50.48 |
| AVG Volume (30 Days) | 9.1M | ★ 11.6M |
| Earning Date | 06-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 765.52 | N/A |
| EPS | ★ 2.51 | N/A |
| Revenue | ★ $1,335,116,000.00 | N/A |
| Revenue This Year | $210.92 | $10.88 |
| Revenue Next Year | $57.22 | $7.69 |
| P/E Ratio | ★ $107.97 | $658.75 |
| Revenue Growth | ★ 205.68 | N/A |
| 52 Week Low | $84.25 | $32.82 |
| 52 Week High | $274.90 | $50.88 |
| Indicator | CRDO | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 71.37 | 41.18 |
| Support Level | $132.85 | $32.82 |
| Resistance Level | N/A | $44.89 |
| Average True Range (ATR) | 27.04 | 1.63 |
| MACD | 3.97 | 0.34 |
| Stochastic Oscillator | 92.61 | 50.35 |
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.